Literature DB >> 10481836

Inhibition of the high affinity myo-inositol transport system: a common mechanism of action of antibipolar drugs?

B Lubrich1, D van Calker.   

Abstract

The mechanism of action of antibipolar drugs like lithium, carbamazepine, and valproate that are used in the treatment of manic-depressive illness, is unknown. Lithium is believed to act through uncompetitive inhibition of inositolmonophosphatase, which results in a depletion of neural cells of inositol and a concomitant modulation of phosphoinositol signaling. Here, we show that lithium ions, carbamazepine, and valproate, but not the tricyclic antidepressant amitriptyline, inhibit at therapeutically relevant concentrations and with a time course similar to their clinical actions the high affinity myo-inositol transport in astrocyte-like cells and downregulate the level of the respective mRNA. Inhibition of inositol uptake could thus represent an additional pathway for inositol depletion, which might be relevant in the mechanism of action of all three antibipolar drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481836     DOI: 10.1016/S0893-133X(99)00037-8

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  17 in total

Review 1.  Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.

Authors:  Jorge A Quiroz; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Neuropsychobiology       Date:  2010-05-07       Impact factor: 2.328

2.  Inositol-related gene knockouts mimic lithium's effect on mitochondrial function.

Authors:  Lilach Toker; Yuly Bersudsky; Inbar Plaschkes; Vered Chalifa-Caspi; Gerard T Berry; Roberto Buccafusca; Dieder Moechars; R H Belmaker; Galila Agam
Journal:  Neuropsychopharmacology       Date:  2013-08-08       Impact factor: 7.853

Review 3.  Ion channel-transporter interactions.

Authors:  Daniel L Neverisky; Geoffrey W Abbott
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-04-20       Impact factor: 8.250

4.  Mood stabilizer psychopharmacology.

Authors:  Todd D Gould; Guang Chen; Husseini K Manji
Journal:  Clin Neurosci Res       Date:  2002-11-14

5.  A model of inositol compartmentation in astrocytes based upon efflux kinetics and slow inositol depletion after uptake inhibition.

Authors:  M Wolfson; Y Bersudsky; E Hertz; V Berkin; E Zinger; L Hertz
Journal:  Neurochem Res       Date:  2000-07       Impact factor: 3.996

6.  Inhibition of inositol monophosphatase by lithium chloride induces selective macrophage apoptosis in atherosclerotic plaques.

Authors:  Inge De Meyer; Wim Martinet; Cor E Van Hove; Dorien M Schrijvers; Vicky Y Hoymans; Luc Van Vaeck; Paul Fransen; Hidde Bult; Guido R Y De Meyer
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

7.  Effect of anti-seizure drugs on serum S100B in patients with focal seizure: a randomized controlled trial.

Authors:  Rituparna Maiti; Biswa Ranjan Mishra; Monalisa Jena; Archana Mishra; Santanu Nath; Anand Srinivasan
Journal:  J Neurol       Date:  2018-09-01       Impact factor: 4.849

Review 8.  Chronic treatment with anti-bipolar drugs causes intracellular alkalinization in astrocytes, altering their functions.

Authors:  Dan Song; Baoman Li; Enzhi Yan; Yi Man; Marina Wolfson; Ye Chen; Liang Peng
Journal:  Neurochem Res       Date:  2012-07-28       Impact factor: 3.996

9.  Up-regulation of cPLA(2) gene expression in astrocytes by all three conventional anti-bipolar drugs is drug-specific and enzyme-specific.

Authors:  Baoman Li; Li Gu; Hongyan Zhang; Jingyang Huang; Ye Chen; Leif Hertz; Liang Peng
Journal:  Psychopharmacology (Berl)       Date:  2007-06-27       Impact factor: 4.530

10.  Astrocytic alkalinization by therapeutically relevant lithium concentrations: implications for myo-inositol depletion.

Authors:  Dan Song; Ting Du; Baoman Li; Liping Cai; Li Gu; Hongmei Li; Ye Chen; Leif Hertz; Liang Peng
Journal:  Psychopharmacology (Berl)       Date:  2008-05-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.